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Apreviously healthy 10-week-old infant presentedwith isolated unilateral facial nerve paralysis which progressed to bilateral paralysis over a 2-
week period. Evaluation including MRI and CTof the brain and facial nerve, CSF evaluation and EMG yielded no diagnosis. A single F508 gene
mutation on the newborn screen prompted sweat chloride testing which confirmed a diagnosis of cystic fibrosis. On measurement of fat-soluble
vitamins, levels of vitaminAwere approximately 10%of the lower normal range, in the absence of objective evidence of pseudotumor cerebri. This
case emphasizes an important association between hypovitaminosis A, cystic fibrosis and facial nerve palsy.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Facial nerve paralysis; Hypovitaminosis A; Pseudotumor cerebri1. Introduction
Facial nerve paralysis is an uncommon occurrence in the
neonatal period. Separating congenital paralysis (trauma,
nuclear agenesis of the facial nerve, Moebius syndrome)
from acquired (Bell palsy, complication of otitis media or
cholesteatoma, Ramsay Hunt syndrome (unilateral periph-
eral facial nerve palsy and herpes zoster infection of the ear),
temporal bone fracture, congenital myasthenic syndrome,
myasthenia gravis or neoplasm) may be difficult in the early
neonatal period [1–3].
Hypovitaminosis A as a cause of acquired facial nerve
paralysis in an infant with cystic fibrosis (CF) has been
reported twice in the literature [4,5]. Both of these cases were
preceded by the development of pseudotumor cerebri. We
report a third case which occurred in a 10-week-old infant in⁎ Corresponding author. Children's Hospital of Wisconsin, Pulmonary
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doi:10.1016/j.jcf.2006.08.001the absence of clinical or radiographic evidence of intra-
cranial hypertension.
2. Report of case
A 10-week-old male infant presented to Children's Hos-
pital of Wisconsin for evaluation of right facial paralysis of 1-
day duration. The infant was the product of a 37-week
gestation and delivered by Cesarean section secondary to
breech presentation. The child's mother is Caucasian and
father is African–American. There were no complications
surrounding the birth. Apgars were scored as 8 and 9, at 1 and
5 min, respectively. In the fourth week of life, the infant's
newborn screen detected a single delta F508 mutation for
cystic fibrosis.
One week prior to scheduled sweat chloride testing, the
patient presented to the emergency department with acute
right facial nerve paralysis. There was no history of trauma
or of recent illness. Review of systems was significant for a
hoarse cry and a recent increase in stool frequency.
On examination, he was a well nourished and developed
child (weight and length at 50th percentile). He was afebrileed by Elsevier B.V. All rights reserved.
Fig. 2. Photograph of patient taken 5 days after initial admission showing
bilateral facial palsy.
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unable to close his right eye and had no visible facial creases
on the right (Fig. 1). There was no movement of the right
face with crying. His anterior fontanelle was soft and flat.
There was a hoarse character to his cry. The remainder of his
examination was normal.
Initial work-up revealed a normal white blood cell count
of 10,100 with a normal differential, hemoglobin of 9.3 g/dl
and a platelet count of 528,000. Other tests included a
normal head computed tomography scan (CT), a lumbar
puncture [showing cerebrospinal fluid (CSF) with 2600 red
blood cells, 4 white blood cells, normal protein and glucose]
and a normal magnetic resonance image (MRI) of the brain
and facial nerve. Serologic testing for Ebstein-Barr virus and
Lyme disease were negative, as was enteroviral and herpes
simplex viral polymerase chain reaction of the CSF. A direct
laryngoscopy was performed which demonstrated normal
motion of the vocal cords.
The infant was seen by neurology with a working diag-
nosis of isolated seventh nerve palsy, likely Bell palsy. A
sweat chloride test done during admission was non-diag-
nostic due to inadequate volume. The patient was discharged.
Three days after discharge, the patient presented to clinic
with bilateral facial palsy (Fig. 2). He was readmitted to the
hospital. His exam was unchanged aside from the new
finding of bilateral facial nerve palsy. Repeat MRI wasFig. 1. Photograph of patient on initial admission demonstrating right-sided
facial paralysis.normal. Electromyography of the facial nerve showed find-
ing consistent with demyelination in the bilateral seventh
cranial nerves. Edrophonium stimulation test was normal.
Sweat chloride test was repeated and revealed levels of
113 mEq/l and 109 mEq/l, diagnostic of cystic fibrosis.
Subsequent genetic studies revealed single F508 and
2307insA mutations. Fat-soluble vitamin studies showed:
vitamin A 0.071 μmol/l (nl 0.63–1.75), vitamin E 2.8 μmol/
l (nlN7) and 25-OH vitamin Db17.5 nmol/l (nl 25–170).
The infant was given supplemental pancreatic enzymes
along with fat-soluble vitamins and within 1-week displayed
complete resolution of his facial nerve palsy. Subsequent
vitamin levels were normal including a vitamin A level of
1.1 μmol/l at 1 year of age. Growth has been excellent with
weight at the 80–90th percentile for age.
3. Discussion
Facial nerve paralysis associated with hypovitaminosis A
has been described four times in the literature [4–7]. Two of
these reported cases involved infants later found to have
cystic fibrosis. Although rare, hypovitaminosis A as a cause
of facial nerve paralysis is important, as in our case, it was
the infant's only presenting symptom.
The mechanism of facial nerve paralysis in association
with hypovitaminosis A is thought to be related to the
development of benign intracranial hypertension (pseudotu-
mor cerebri). The pathophysiology of benign intracranial
hypertension resulting from hypovitaminosis A is poorly
understood, though may relate to decreased cerebrospinal
fluid reabsorption [8]. In all but one of the four reference
cases, infants displayed evidence of increased intracranial
pressure (bulging fontanelle, abnormal imaging, increase in
CSF opening pressures) at the time of presentation. A single
reference case reported facial nerve paralysis preceding the
development of pseudotumor cerebri [6].
The possibility of vitamin E deficiency contributing to the
facial nerve paralysis was also considered, though typically
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flexes, ataxia and muscle weakness. Recent studies have also
noted an association between prolonged vitamin E deficiency
in CF infants and lower subsequent cognitive performance
[9,10]. Nevertheless, it is possible that both vitamin A and E
deficiencies may have contributed to the neuropathy in this
case.
Interestingly, pseudotumor cerebri has also occurred in
children with cystic fibrosis and hypervitaminosis A [11,12].
This is thought to be due to a “refeeding syndrome” during
pancreatic enzyme and vitamin supplementation to correct
malnutrition, though the exact mechanism is unclear. A
related hypothesis proposes that intracranial hypertension in
CF may be related to “catch-up growth” [13]. This is based
on the concept that refeeding malnourished children results
in more rapid growth of the brain compared to the skull vault,
potentially causing the increased intracranial pressure. Katz-
nelson proposed that the factors that cause intracranial hy-
pertension in cystic fibrosis may be unrelated to vitamin A
status, but rather potentially due to raised venous pressure
caused by intrathoracic obstruction seen in CF [14].
In our case, pseudotumor cerebri was never documented
and the infant displayed no objective findings of increased
intracranial pressure. Two MRI scans, a CT and multiple
physical exams did not suggest increased intracranial pres-
sure. A CSF opening pressure was not documented with the
lumbar puncture, so we lack this objective finding on pre-
sentation. The patient's facial nerve paralysis rapidly resolved
with pancreatic enzyme and fat-soluble vitamin supplemen-
tation as was also the circumstance in the previously reported
cases. Given these findings, we question whether there is a
distinct pathophysiology underlying the cranial neuropathy in
our patient. Can hypovitaminosis A, in the absence of pseu-
dotumor cerebri, lead to a focal neuropathy? If so, this would
explain the presentation of our patient and that of Cornfield
and Cooke, who also lacked findings of increased intracranial
pressure at presentation.In this report, we present a child with facial nerve pa-
ralysis associated with vitamin A deficiency and cystic fi-
brosis. Cystic fibrosis and hypovitaminosis A should be
considered in the differential diagnosis of all infants with
suspected acquired facial nerve palsy. Based on this case and
the others, we recommend including facial nerve palsy as a
potential presenting symptom in infants with cystic fibrosis.
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